Official UK procurement notice
Aseptically Manipulated or Terminally Sterile Medicinal Products Framework (Lot 5)
Authority: CORNWALL PARTNERSHIP NHS FOUNDATION TRUST (Central government)
What is being bought
Published requirement descriptionThe supply of aseptically manipulated or terminally sterile products to NHS Trusts within the boundaries of the Peninsula Purchasing and Supply Alliance (PPSA). Products include national dose-banded cytotoxic and non-cytotoxic batch and patient specific medicines in ready-to-use infusion bags, pre-filled syringes & elastomeric devices.
This procurement is being managed by the PPSA on behalf of the Royal Devon University Healthcare NHS Foundation Trust acting for itself and for Gloucestershire Hospitals NHS Trust, Great Western Hospitals NHS Foundation Trust, Royal Cornwall Hospitals NHS Trust, Salisbury NHS Foundation Trust, Somerset NHS Foundation Trust, Torbay & South Devon NHS Foundation Trust, University Hospitals Plymouth NHS Trust, North Bristol NHS Trust, University Hospitals Bristol & Weston NHS Foundation Trust and the Royal United Hospital Bath NHS Foundation Trust.
CPV: Infusion solutions · Injectable solutions · Intravenous fluids · Pharmaceutical products · Toxins · Various medicinal products
How this framework works
From the published notice- Places
- up to 10 suppliers · 5 bids received (0.5 per place) · 5 appointed
The lotProcurement structure
single lot · value publishedLot #1Supply of various products in bags, pre-filled syringes to include Arsenic Trioxide,…AwardedPublished value£80,000,000
Supply of various products in bags, pre-filled syringes to include Arsenic Trioxide, Avelumab, Azacitidine, Bendamustine, Bevacizumab, Blinatumomab, Brentuximab, Bupivacaine, Carfilzomib, Cetuximab, Daratumumab, Eribulin Mesylate, Etoposide, Fludarabine Fluorouracil elastomeric devices, Ifosfamide, Infliximab, Ipilimumab, Methotrexate, Natalizumab, Obinutuzumab, Paclitaxel Albumin, Panitumumab, Pemetrexed, Pertuzumab, Rituximab, Trastuzumab, Trastuzumab Emtansine, Vedolizumab, Vinorelbine.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- QA Processes & Service: 90%
- Social Value: 10%
Published award criteria (3)
- QA Processes & Service: 90%
- Social Value: 10%
- Price: 0%
- “Aseptically Manipulated or Terminally Sterile Medicinal Products…” is a framework: the contest is a place on its panel, up to 10 suppliers, not a single contract.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Unspecified in notice
- Recurring procurement
- No (one-off requirement)
- First published
- 4 May 2023, 14:09 BST
- Last source update
- 20 Aug 2024, 10:04 BST
- Award evaluation window
- 6 Jun 2023 – …
- Authority reference
T22/0446 Lot 5 Framework- FTS notice number
2024/S 000-026412- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-03c658Find a Tender
Publisher note: The following Trusts may join any Contract(s) awarded from the Tender at any time during the Contract Period including Dorset County Hospital NHS Foundation Trust, Jersey General Hospital, Princess Elizabeth Hospital, Guernsey and University Hospitals Dorset NHS Foundation Trust.
How it was run
Official notice- Appointment period ends
- 13 Jul 2023, 12:00 BST
- Submission channel
- {"electronicSubmission","written"}
- Accepted languages
- en
- Bid validity
- 240 days from the deadline
- Bids opened
- 6 Jun 2023, 09:00 BST
Timeline
6 Jun 2023 → 20 Aug 2024 · 3 dates- Bids opened6 Jun 2023, 09:00 BST
- Admission / appointment period endsperiod end, not a bid countdown13 Jul 2023, 12:00 BST
- Notice published20 Aug 2024, 10:04 BST
Notice history
3 events · 4 releases on Find a Tender · since 18 May 2023- Deadline moved to 16 Jun 2023, 12:00 BST18 May 2023, 12:09 BST+11 days · was 5 Jun 2023, 14:00 BST
- Deadline moved to 13 Jul 2023, 12:00 BST8 Jun 2023, 15:24 BST+27 days · was 16 Jun 2023, 12:00 BST
- Status changed to complete20 Aug 2024, 10:04 BST
Published amendments (2 · 2 deadline changes)
| When | What | Before | After | Shift |
|---|---|---|---|---|
| — | DeadlineTime limit for receipt of tenders · IV.2.2 | 5 Jun 2023 | 16 Jun 2023 | +11 d |
| — | Bid openingConditions for opening of tenders · IV.2.7 | 6 Jun 2023 | 16 Jun 2023 | +10 d |
| — | DeadlineTime limit for receipt of tenders · IV.2.2 | 16 Jun 2023 | 13 Jul 2023 | +27 d |
| — | Bid openingConditions for opening of tenders · IV.2.7 | 6 Jun 2023 | 13 Jul 2023 | +37 d |
| — | TextDuration of Contract · II.2.7 | 48 months | 36 months | |
| — | TextDescription of options · II.2.11 | Options: No | Option to extend for any period up to 12 months. |
2 amendments published without a description.
Routine re-releases (4)
- 2023-05: 1 release · 4 May 2023
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast5 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
All 3 of these contracts carry the same published figure, £20,000,000, the framework's maximum for the whole notice, not each contract's own value. They are not eleven separate sums.
Contract 4 - Quantum Pharmaceutical Limited
- Signed
- 18 Jun 2024
- Value
- ceiling above
- Status
- active
Contract 3 - Sciensus Pharma Services Ltd
- Signed
- 30 May 2024
- Value
- £19,000,000
- Status
- active
Contract 2 - Qualasept Ltd t/a Bath ASU
- Signed
- 28 May 2024
- Value
- ceiling above
- Status
- active
Contract 1 - Baxter Healthcare Ltd
- Signed
- 24 May 2024
- Value
- ceiling above
- Status
- active
Contract 5 - Liverpool University Hospitals NHS Foundation Trust
- Signed
- 11 Apr 2024
- Value
- £1,000,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 5bids · 5 electronic | — | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Peninsula Purchasing & Supply AllianceMediation bodyReview bodyReview contact point
Framework contractors & participating bidders
5 commercial parties on the notice- Baxter Healthcare LtdFramework contractor
- Liverpool University Hospitals NHS Foundation Trust Framework contractor
- Qualasept Ltd t/a Bath ASUFramework contractor
- Quantum Pharmaceutical LimitedFramework contractor
- Sciensus Pharma Services LimitedFramework contractor
Official documents & specifications (1)
Official links; attachments are not copiedTender pack and attachments
- Technical selection criteria